Press Releases
Please find the latest press releases from Avextra here.
Beyond Oil: Avextra Launches Novel Cannabis Granulate – A new perspective in patient care
Bensheim, June 30, 2026 – Avextra is introducing a novel cannabis granulate based on a balanced THC/CBD extract, designed for the preparation of capsule-based formulations…
Neues Dronabinol-Konzentrat optimiert Rezepturherstellung in der Apotheke
Bensheim, 5. Mai 2026 – Avextra erweitert mit dem Dronabinol Konzentrat Avextra 31 mg/ml sein Portfolio an cannabisbasierten Rezepturarzneimitteln…
Novel Pharmaceutical Avextra Capsule Enhances Patient Experience and Treatment Acceptance
Bensheim, Germany, December 3rd 2025 — How can therapy with Cannabis-based medicines (CbM) be designed to be not only therapeutically proven, but also patient-friendly and safe…
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
First patient enrolled in randomized, placebo-controlled study Bensheim, 24. October 2025 – Neurodegenerative diseases represent one of the biggest challenges of our time. In Germany alone, there are currently...
First Patient Included Marks Major Milestone in EU-Funded Clinical Trial
Bensheim, Germany, August 11, 2025 – PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin…
Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients
Bensheim, Germany, 13th June 2025 — New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines…
Veteran Banker Joins Avextra’s Supervisory Board
Bensheim, Germany, April 3, 2025 – Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board,…
Avextra Showcases Study Findings on World Sleep Day 2025
Bensheim, Germany – 14 March 2025 – In anticipation of World Sleep Day, Avextra has revealed findings from its IMPACT study at the German Pain and Palliative Care Days, organised by the German Pain Association…
Beyond Oil: Avextra Launches Novel Cannabis Granulate – A new perspective in patient care
Bensheim, June 30, 2026 – Avextra is introducing a novel cannabis granulate based on a balanced THC/CBD extract, designed for the preparation of capsule-based formulations…
Neues Dronabinol-Konzentrat optimiert Rezepturherstellung in der Apotheke
Bensheim, 5. Mai 2026 – Avextra erweitert mit dem Dronabinol Konzentrat Avextra 31 mg/ml sein Portfolio an cannabisbasierten Rezepturarzneimitteln…
Novel Pharmaceutical Avextra Capsule Enhances Patient Experience and Treatment Acceptance
Bensheim, Germany, December 3rd 2025 — How can therapy with Cannabis-based medicines (CbM) be designed to be not only therapeutically proven, but also patient-friendly and safe…
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
First patient enrolled in randomized, placebo-controlled study Bensheim, 24. October 2025 – Neurodegenerative diseases represent one of the biggest challenges of our time. In Germany alone, there are currently...
First Patient Included Marks Major Milestone in EU-Funded Clinical Trial
Bensheim, Germany, August 11, 2025 – PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin…
Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients
Bensheim, Germany, 13th June 2025 — New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines…
Veteran Banker Joins Avextra’s Supervisory Board
Bensheim, Germany, April 3, 2025 – Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board,…
Avextra Showcases Study Findings on World Sleep Day 2025
Bensheim, Germany – 14 March 2025 – In anticipation of World Sleep Day, Avextra has revealed findings from its IMPACT study at the German Pain and Palliative Care Days, organised by the German Pain Association…
PRESS CONTaCT
